sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
31-Oct-2014 15:29
US Eastern Time




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 851-875 out of 913.

<< < 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 > >>

Public Release: 14-Dec-2012
We're all living longer, but longevity increases not benefitting everybody
Global lifespans have risen dramatically in the past 40 years, but the increased life expectancy is not benefitting everybody equally, say University of Toronto researchers. In particular, adult males from low- and middle-income countries are losing ground.

Contact: Terry Lavender
University of Toronto Faculty of Applied Science & Engineering

Public Release: 13-Dec-2012
Agricultural, health education goes global via cellphone animations
Many people in developing countries have cellphones that allow them to watch videos and play interactive games. Now agricultural researchers and health educators are using this technology to help those in the developing world address some of the most challenging issues they face -- and at a fraction of the cost of traditional development aid education.
ADM Institute for Post-harvest Losses at University of Illinois

Contact: Diana Yates
University of Illinois at Urbana-Champaign

Public Release: 13-Dec-2012
Lives in the Balance: Delivering Medical Innovations for Neglected Patients and Populations
Millions of patients still waiting for medical 'breakthroughs' against neglected diseases
Despite important progress in research and development for global health over the past decade, only a small fraction of new medicines developed between 2000 and 2011 were for the treatment of neglected diseases, highlighting the "fatal imbalance" between global disease burden and drug development, said Doctors Without Borders/Médecins Sans Frontières and the Drugs for Neglected Diseases initiative, in an analysis to be presented today at an international conference aimed at spurring medical innovations for these diseases.

Contact: Oliver Yun
Drugs for Neglected Diseases Initiative

Public Release: 13-Dec-2012
Study finds years living with disease, injury increasing globally
No matter where they live, how much education they have, or what their incomes are, people have similar perceptions on the impact of diseases and injuries. This finding is part of a collaborative project, the Global Burden of Disease Study 2010. Launched by Harvard School of Public Health, Institute for Health Metrics and Evaluation at the University of Washington, and 300 institutions worldwide, GBD 2010 is the single largest scientific effort ever conducted to quantify levels and trends in health worldwide.
Bill & Melinda Gates Foundation

Contact: Marge Dwyer
Harvard School of Public Health

Public Release: 13-Dec-2012
PLOS Pathogens
Ebola virus uses a protein decoy to subvert the host immune response
In a study published today in the open-access journal PLOS Pathogens, researchers at Emory University have discovered a potentially important mechanism by which the Ebola virus alters and evades the immune response of its infected host.

Contact: Gina Alvino

Public Release: 13-Dec-2012
Blood pressure, smoking and alcohol: The health risks with the biggest global burden
Over 9 million people died as a consequence of high blood pressure in 2010, making it the health risk factor with the greatest toll worldwide, say experts.

Contact: Sam Wong
Imperial College London

Public Release: 13-Dec-2012
New study brings long-sought vaccines for deadly parasite closer to reality
One major cause of illness from food-borne diseases is the parasite Toxoplasma gondii (T. gondii). New insights into how the immune system combats T. gondii are provided in a study published by Cell Press December 13th in the journal Immunity. The findings could lead to the development of long-sought vaccines to protect against T. gondii and related parasites.

Contact: Mary Beth OLeary
Cell Press

Public Release: 12-Dec-2012
American Journal of Tropical Medicine and Hygiene
Ceramic indoor cookstove use did not significantly lower child pneumonia risk in rural Kenya
Inexpensive, locally produced ceramic cookstoves may produce less smoke than traditional indoor three-stone firepits, but they don't significantly reduce indoor air pollution or the risk of pneumonia in young children, according to results from a small, year-long observational study by researchers working in rural Kenya.

Contact: Preeti Singh
Burness Communications

Public Release: 12-Dec-2012
PLOS Biology
UGA researchers find algal ancestor is key to how deadly pathogens proliferate
Long ago, when life on Earth was in its infancy, a group of small single-celled algae propelled themselves through the vast prehistoric ocean by beating whip like tails called flagella. It's a relatively unremarkable tale, except that now, more than 800 million years later, these organisms have evolved into parasites that threaten human health, and their algal past in the ocean may be the key to stopping them.

Contact: Boris Striepen
University of Georgia

Public Release: 11-Dec-2012
DNDi is awarded USD 17.3 million from UNITAID to spur development and delivery of child-adapted ARVs
The Drugs for Neglected Diseases initiative welcomes the announcement by UNITAID to grant up to USD 17.3 million to the organization for its pediatric HIV program.

Contact: Violaine Dallenbach
Drugs for Neglected Diseases Initiative

Public Release: 11-Dec-2012
New tuberculosis drug trial begins in South Africa
Case Western Reserve University School of Medicine and AstraZeneca, a global biopharmaceutical company, today announced the first patient enrolled in a Phase 2a trial to assess the effectiveness of AZD5847, a new test drug for patients with tuberculosis, including patients with HIV co-infection. The study is sponsored by the National Institute of Allergy and Infectious Diseases, part of the US National Institutes of Health.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jessica Studeny
Case Western Reserve University

Public Release: 11-Dec-2012
NIH scientists reflect on gains in emerging infectious disease awareness, research and response
In a new essay, National Institute of Allergy and Infectious Diseases director Anthony S. Fauci, M.D., and David Morens, M.D., reflect on what has been learned about emerging infectious diseases in the two decades since a major report from the US Institute of Medicine rekindled interest in this important topic.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Anne A. Oplinger
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 11-Dec-2012
PLOS Medicine
Long-term public health support needed to tackle infectious disease outbreaks
Outbreaks of infectious diseases, such as swine flu (H1N1) threaten global health and should be considered by funding agencies and humanitarian organizations as development issues rather than emergency situations, requiring long-term support and investment, according to US experts writing in this week's PLOS Medicine.

Contact: Sumrina Yousufzai

Public Release: 6-Dec-2012
New oral drug candidate for African sleeping sickness
A new oral-only treatment for sleeping sickness has entered Phase II/III clinical study in patients with late-stage sleeping sickness in the Democratic Republic of the Congo and soon in Central African Republic. The study, initiated by the Drugs for Neglected Diseases initiative and its partners, will test the efficacy and safety of fexinidazole, with once-daily tablets for ten days.

Contact: Violaine Dällenbach
Drugs for Neglected Diseases Initiative

Public Release: 5-Dec-2012
X-ray laser helps slay parasite that causes sleeping sickness
An international team of scientists, using the world's most powerful X-ray laser, has revealed the 3D structure of a key enzyme that enables the single-celled parasite that causes African trypanosomiasis (or sleeping sickness) in humans. With the elucidation of the 3D structure of the cathepsin B enzyme, it will be possible to design new drugs to inhibit the parasite that causes sleeping sickness, leaving the infected human unharmed.
Department of Energy

Contact: Jenny Green
Arizona State University

Public Release: 5-Dec-2012
Acta Biomaterialia
New technique to deliver stem cell therapy may help damaged eyes regain their sight
Engineers at the University of Sheffield have developed a new technique for delivering stem cell therapy to the eye which they hope will help the natural repair of eyes damaged by accident or disease. This could help millions of people across the world retain – or even regain - their sight.
Engineering & Physical Sciences Research Council, Wellcome Trust

Contact: Abigail Chard
University of Sheffield

Public Release: 4-Dec-2012
Einstein researchers receive 2 Grand Challenges Explorations grants to combat HIV and TB
Scientists at Albert Einstein College of Medicine of Yeshiva University have been awarded two Grand Challenges Explorations grants from the Bill & Melinda Gates Foundation for their innovative global health and development research projects.
Bill & Melinda Gates Foundation

Contact: Kim Newman
Albert Einstein College of Medicine

Public Release: 4-Dec-2012
Queen Mary, University of London receives funding for gut function biomarker research
Queen Mary, University of London announced today that it will receive funding through the Biomarkers of Gut Function and Health program within the Grand Challenges in Global Health initiative. This initiative was launched by the Bill & Melinda Gates Foundation to overcome persistent bottlenecks preventing the creation of new and better health solutions for the developing world.
Bill & Melinda Gates Foundation

Contact: Katrina Coutts
Queen Mary, University of London

Public Release: 3-Dec-2012
Proceedings of the National Academy of Sciences
Malaria parasite's masquerade ball could be coming to an end
More than a million people die each year of malaria caused by different strains of the Plasmodium parasite transmitted by the Anopheles mosquito. By figuring out how the most dangerous strain evades the watchful eye of the immune system, researchers from the Hebrew University of Jerusalem have now paved the way for the development of new approaches to cure this acute infection.
Israel Academy of Sciences and Humanities

Contact: Dov Smith
The Hebrew University of Jerusalem

Public Release: 30-Nov-2012
Emerging vector-borne diseases create new public health challenge
Human activities are advancing the spread of vector-borne, zoonotic diseases such as West Nile virus, Lyme disease and dengue fever, report scientists publishing a series of papers today in the journal the Lancet.
National Science Foundation

Contact: Cheryl Dybas
National Science Foundation

Public Release: 30-Nov-2012
Electrically spun fabric offers dual defense against pregnancy, HIV
Electrically spun cloth with nanometer-sized fibers show promise as a cheap, versatile platform to simultaneously offer contraception and prevent HIV. New funding from the Bill & Melinda Gates Foundation will further test the system's versatility and feasibility.
National Institutes of Health, Bill & Melinda Gates Foundation

Contact: Hannah Hickey
University of Washington

Public Release: 29-Nov-2012
X-ray laser helps fight sleeping sickness
An international group of scientists working at SLAC has mapped a weak spot in the parasite that causes African sleeping sickness, pinpointing a promising new target for treating a disease that kills tens of thousands of people each year.
US Department of Energy

Contact: Andy Freeberg
DOE/SLAC National Accelerator Laboratory

Public Release: 29-Nov-2012
X-rays expose blueprint for possible sleeping sickness drug
Using the world's most powerful X-ray laser, scientists have exposed a possible Achilles' heel of the sleeping sickness parasite that threatens more than 60 million people in sub-Saharan Africa. The sophisticated analysis revealed the blueprint for a molecular plug that can selectively block a vital enzyme of the parasite Trypanosoma brucei. Plugging such a tailor-made molecule into the right place of the enzyme would render it inactive, thereby killing the parasite.

Contact: Thomas Zoufal
Helmholtz Association

Public Release: 28-Nov-2012
Report finds Big Pharma is doing more for access to medicine in developing countries
The latest Access to Medicine Index, which ranks the top 20 pharmaceutical companies on their efforts to improve access to medicine in developing countries, finds that the industry is doing more than it was two years ago. Seventeen out of the 20 companies perform better than they did at the time of the last Index report in 2010.
Bill & Melinda Gates Foundation, Dutch Ministry of Foreign Affairs, UK Department for International Development, and others

Contact: Suzanne Wolf
Access to Medicine Foundation

Public Release: 27-Nov-2012
Measles vaccine given with a microneedle patch could boost immunization programs
Measles vaccine given with painless and easy-to-administer microneedle patches can immunize against measles at least as well as vaccine given with conventional hypodermic needles, according to research done by the Georgia Institute of Technology and the Centers for Disease Control and Prevention.
Centers for Disease Control and Prevention, National Institutes of Health

Contact: John Toon
Georgia Institute of Technology

Showing releases 851-875 out of 913.

<< < 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 > >>